These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 2839917)
1. The influence of donor factors other than serologic status on transmission of cytomegalovirus to transplant recipients. Chou SW; Norman DJ Transplantation; 1988 Jul; 46(1):89-93. PubMed ID: 2839917 [TBL] [Abstract][Full Text] [Related]
2. Prevention of CMV infection by screening for CMV antibodies in renal allograft recipients and their blood and kidney donors. Metselaar HJ; Ploeg RJ; Van Loon AM; Weiland HT; Rothbarth PH; Paul LC; Brand A; Schaafsma R; Hendriks GF; Jeekel J Scand J Infect Dis; 1988; 20(2):135-9. PubMed ID: 2840730 [TBL] [Abstract][Full Text] [Related]
3. Incidence and morbidity of cytomegalovirus disease associated with a seronegative recipient receiving seropositive donor-specific transfusion and living-related donor transplantation. A multicenter evaluation. Weir MR; Henry ML; Blackmore M; Smith J; First MR; Irwin B; Shen S; Genemans G; Alexander JW; Corry RJ Transplantation; 1988 Jan; 45(1):111-6. PubMed ID: 2827352 [TBL] [Abstract][Full Text] [Related]
4. Acquisition of donor strains of cytomegalovirus by renal-transplant recipients. Chou SW N Engl J Med; 1986 May; 314(22):1418-23. PubMed ID: 3010114 [TBL] [Abstract][Full Text] [Related]
5. The risk of transfusion-acquired CMV infection in seronegative solid-organ transplant recipients receiving non-WBC-reduced blood components not screened for CMV antibody (1984 to 1996): experience at a single Canadian center. Preiksaitis JK; Sandhu J; Strautman M Transfusion; 2002 Apr; 42(4):396-402. PubMed ID: 12076284 [TBL] [Abstract][Full Text] [Related]
6. Cytomegalovirus as a risk factor in living-related renal transplantation. A prospective study. Pollak R; Barber PL; Prusak BF; Mozes MF Ann Surg; 1987 Mar; 205(3):302-4. PubMed ID: 3030201 [TBL] [Abstract][Full Text] [Related]
7. [Importance of screening for antibodies to cytomegalovirus in organ transplantation]. Milbradt H; Flik J; Stangel W; Heigel R Beitr Infusionsther; 1990; 26():33-6. PubMed ID: 1703866 [TBL] [Abstract][Full Text] [Related]
8. Viral infections in renal transplant donors and their recipients: a prospective study. Balfour HH; Slade MS; Kalis JM; Howard RJ; Simmons RL; Najarian JS Surgery; 1977 May; 81(5):487-92. PubMed ID: 191948 [TBL] [Abstract][Full Text] [Related]
9. Diagnostic utility of monitoring cytomegalovirus-specific immunity by QuantiFERON-cytomegalovirus assay in kidney transplant recipients. Deborska-Materkowska D; Perkowska-Ptasinska A; Sadowska A; Gozdowska J; Ciszek M; Serwanska-Swietek M; Domagala P; Miszewska-Szyszkowska D; Sitarek E; Jozwik A; Kwiatkowski A; Durlik M BMC Infect Dis; 2018 Apr; 18(1):179. PubMed ID: 29661141 [TBL] [Abstract][Full Text] [Related]
10. Donor and recipient CMV serostatus and antigenemia after renal transplantation: an analysis of 486 patients. Hughes D; Hafferty J; Fulton L; Friend P; Devaney A; Loke J; Welsh KI; Handa A; Klenerman P J Clin Virol; 2008 Feb; 41(2):92-5. PubMed ID: 18032098 [TBL] [Abstract][Full Text] [Related]
11. An assessment of donor-to-recipient transmission patterns of human cytomegalovirus by analysis of viral genomic variants. Manuel O; Pang XL; Humar A; Kumar D; Doucette K; Preiksaitis JK J Infect Dis; 2009 Jun; 199(11):1621-8. PubMed ID: 19385736 [TBL] [Abstract][Full Text] [Related]
12. Immunoglobulin M to cytomegalovirus in primary and reactivation infections in renal transplant recipients. Chou S; Kim DY; Scott KM; Sewell DL J Clin Microbiol; 1987 Jan; 25(1):52-5. PubMed ID: 3025251 [TBL] [Abstract][Full Text] [Related]
13. Neutralizing antibody responses to reinfecting strains of cytomegalovirus in transplant recipients. Chou SW J Infect Dis; 1989 Jul; 160(1):16-21. PubMed ID: 2543709 [TBL] [Abstract][Full Text] [Related]
14. The transplanted kidney as a source of cytomegalovirus infection. Ho M; Suwansirikul S; Dowling JN; Youngblood LA; Armstrong JA N Engl J Med; 1975 Nov; 293(22):1109-12. PubMed ID: 171567 [TBL] [Abstract][Full Text] [Related]
15. Infections with cytomegalovirus and other herpesviruses in 121 liver transplant recipients: transmission by donated organ and the effect of OKT3 antibodies. Singh N; Dummer JS; Kusne S; Breinig MK; Armstrong JA; Makowka L; Starzl TE; Ho M J Infect Dis; 1988 Jul; 158(1):124-31. PubMed ID: 2839576 [TBL] [Abstract][Full Text] [Related]
16. Should heart-lung transplant donors and recipients be matched according to cytomegalovirus serologic status? Novick RJ; Menkis AH; McKenzie FN; Reid KR; Ahmad D J Heart Transplant; 1990; 9(6):699-706. PubMed ID: 2177496 [TBL] [Abstract][Full Text] [Related]
17. The role of pretransplant immunity in protection from cytomegalovirus disease following renal transplantation. Smiley ML; Wlodaver CG; Grossman RA; Barker CF; Perloff LJ; Tustin NB; Starr SE; Plotkin SA; Friedman HM Transplantation; 1985 Aug; 40(2):157-61. PubMed ID: 2992130 [TBL] [Abstract][Full Text] [Related]
18. Cytomegalovirus serologic status and postoperative infection correlated with risk of developing chronic rejection after pulmonary transplantation. Keenan RJ; Lega ME; Dummer JS; Paradis IL; Dauber JH; Rabinowich H; Yousem SA; Hardesty RL; Griffith BP; Duquesnoy RJ Transplantation; 1991 Feb; 51(2):433-8. PubMed ID: 1847251 [TBL] [Abstract][Full Text] [Related]
19. CMV mismatch does not affect patient and graft survival in UK renal transplant recipients. Johnson RJ; Clatworthy MR; Birch R; Hammad A; Bradley JA Transplantation; 2009 Jul; 88(1):77-82. PubMed ID: 19584684 [TBL] [Abstract][Full Text] [Related]